Specifically, phosphorylation of S111 influences the promotion of the epithelial-mesenchymal transition (EMT), and this specific PTM is known to decrease the repressive activity of LSD1, which is associated with breast cancer stem cell development. Here, KDM1A is linked to breast cancer.